NCT00260156
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals Basel, Switzerland
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
155 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT03270436
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- University of Arkansas for Medical Sciences Northwest Fayetteville, Arkansas, United States
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Leeds, United Kingdom
NCT04276428
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Clinical Research Hospital Tokyo Shinjuku-ku, Jp-13, Japan
- P-one clinic Hachiōji, Tokyo, Japan
- Yokohama Minoru Clinic Yokohama, Japan
NCT02229227
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Searcy, Arkansas, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Los Angeles, California, United States
Completed
Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic
NCT04633941
- Conditions
- Bariatric Surgery Candidate, Body Weight, Diabetes Mellitus, +12 more
- Locations
-
- Singapore General Hospital Singapore
NCT03797885
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novo Nordisk Investigational Site Almada, Portugal
- Novo Nordisk Investigational Site Caldas da Rainha, Portugal
- Novo Nordisk Investigational Site Leiria, Portugal
- Novo Nordisk Investigational Site Lisbon, Portugal
NCT02964247
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Birmingham, Alabama, United States
- Novo Nordisk Investigational Site Montgomery, Alabama, United States
- Novo Nordisk Investigational Site Tucson, Arizona, United States
- Novo Nordisk Investigational Site Lancaster, California, United States
NCT03603704
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- P-one clinic Hachiōji, Tokyo, Japan
- Sumida Hospital Sumida-ku, Tokyo, Japan
- Hakata Clinic Fukuoka, Japan
NCT04630691
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified